https://wikimd.com/index.php?action=history&feed=atom&title=Retosiban 2026-04-23T06:12:29Z Revision history for this page on the wiki MediaWiki 1.44.2 https://wikimd.com/index.php?title=Retosiban&diff=5368406&oldid=prev 2024-03-06T03:54:02Z

<p>CSV import</p> <p><b>New page</b></p><div>[[File:Retosiban.png|thumb|{{PAGENAME}}]]&lt;br&gt;&#039;&#039;&#039;Retosiban&#039;&#039;&#039; is a [[drug]] that is classified as an [[oxytocin receptor antagonist]]. It was developed by [[GlaxoSmithKline]] for the management of [[preterm labor]]. <br /> <br /> == History ==<br /> <br /> Retosiban was first synthesized by GlaxoSmithKline in the early 21st century. The drug was developed as a potential treatment for preterm labor, a condition that affects approximately 10% of all pregnancies worldwide. <br /> <br /> == Mechanism of Action ==<br /> <br /> Retosiban works by blocking the action of [[oxytocin]], a hormone that stimulates uterine contractions. By inhibiting the oxytocin receptor, Retosiban can potentially delay or prevent the onset of labor.<br /> <br /> == Clinical Trials ==<br /> <br /> Several [[clinical trials]] have been conducted to evaluate the safety and efficacy of Retosiban. In Phase II trials, the drug was found to be well-tolerated and showed promising results in delaying preterm labor. However, further studies are needed to confirm these findings and to determine the optimal dosing regimen.<br /> <br /> == Potential Applications ==<br /> <br /> In addition to its potential use in preterm labor, Retosiban may also have applications in other conditions that involve oxytocin, such as [[postpartum hemorrhage]], [[dysmenorrhea]], and certain psychiatric disorders.<br /> <br /> == See Also ==<br /> <br /> * [[Oxytocin receptor antagonist]]<br /> * [[Preterm labor]]<br /> * [[Clinical trials]]<br /> * [[GlaxoSmithKline]]<br /> <br /> [[Category:Drugs]]<br /> [[Category:Pharmacology]]<br /> [[Category:Oxytocin receptor antagonists]]<br /> {{Pharmacology-stub}}</div>

Prab